dc.contributor.author | Tan, WK | en_US |
dc.contributor.author | Maroni, R | en_US |
dc.contributor.author | Offman, J | en_US |
dc.contributor.author | Zamani, S | en_US |
dc.contributor.author | Di Pietro, M | en_US |
dc.contributor.author | O'Donovan, M | en_US |
dc.contributor.author | Sasieni, P | en_US |
dc.contributor.author | Fitzgerald, RC | en_US |
dc.date.accessioned | 2024-05-13T11:16:48Z | |
dc.date.issued | 2024-05 | en_US |
dc.identifier.issn | 0016-5085 | en_US |
dc.identifier.uri | https://qmro.qmul.ac.uk/xmlui/handle/123456789/96825 | |
dc.format.extent | s - 196 | en_US |
dc.publisher | Elsevier | en_US |
dc.relation.ispartof | Gastroenterology | en_US |
dc.title | 861 MODELLING FROM A MULTICENTRE, PRAGMATIC, RANDOMISED CONTROLLED TRIAL IDENTIFIES THE TARGET SCREENING POPULATION AND EXPECTED YIELD FOR BARRETT'S ESOPHAGUS AND ESOPHAGEAL CANCER DIAGNOSES | en_US |
dc.type | Article | |
dc.identifier.doi | 10.1016/s0016-5085(24)00946-6 | en_US |
pubs.issue | 5 | en_US |
pubs.notes | Not known | en_US |
pubs.volume | 166 | en_US |
rioxxterms.funder | Default funder | en_US |
rioxxterms.identifier.project | Default project | en_US |
qmul.funder | Cancer Research UK Prevention Trials Unit (CPTU) core funding::Cancer Research UK | en_US |
qmul.funder | Cancer Research UK Prevention Trials Unit (CPTU) core funding::Cancer Research UK | en_US |